» Articles » PMID: 38348026

Causal Relationship Between Immune Cells and Neurodegenerative Diseases: a Two-sample Mendelian Randomisation Study

Overview
Journal Front Immunol
Date 2024 Feb 13
PMID 38348026
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is increasing evidence that the types of immune cells are associated with various neurodegenerative diseases. However, it is currently unclear whether these associations reflect causal relationships.

Objective: To elucidate the causal relationship between immune cells and neurodegenerative diseases, we conducted a two-sample Mendelian randomization (MR) analysis.

Materials And Methods: The exposure and outcome GWAS data used in this study were obtained from an open-access database (https://gwas.mrcieu.ac.uk/), the study employed two-sample MR analysis to assess the causal relationship between 731 immune cell features and four neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). All immune cell data was obtained from Multiple MR methods were used to minimize bias and obtain reliable estimates of the causal relationship between the variables of interest and the outcomes. Instrumental variable selection criteria were restricted to ensure the accuracy and effectiveness of the causal relationship between species of immune cells and the risk of these neurodegenerative diseases.

Results: The study identified potential causal relationships between various immune cells and different neurodegenerative diseases. Specifically, we found that 8 different types of immune cells have potential causal relationships with AD, 1 type of immune cells has potential causal relationships with PD, 6 different types of immune cells have potential causal relationships with ALS, and 6 different types of immune cells have potential causal relationships with MS.

Conclusion: Our study, through genetic means, demonstrates close causal associations between the specific types of immune cells and AD, PD, ALS and MS, providing useful guidance for future clinical researches.

Citing Articles

Genetically determined physical activity levels, sedentary behaviours, and their association with the risk of age-related macular degeneration.

Zhou X, Wu J, Shen Y, He S, Guan H, Shen L J Int Med Res. 2025; 53(2):3000605251318198.

PMID: 39953382 PMC: 11829306. DOI: 10.1177/03000605251318198.


Influence of immune cells and inflammatory factors on Alzheimer's disease axis: evidence from mediation Mendelian randomization study.

Linzhu , Zhang J, Fan W, Su C, Jin Z BMC Neurol. 2025; 25(1):49.

PMID: 39910474 PMC: 11796147. DOI: 10.1186/s12883-025-04057-z.


Identification of iron metabolism-related genes in coronary heart disease and construction of a diagnostic model.

Zhu L, Zhang J, Fan W, Su C, Jin Z Front Cardiovasc Med. 2024; 11:1409605.

PMID: 39610972 PMC: 11602506. DOI: 10.3389/fcvm.2024.1409605.


Genetic association of type 2 diabetes mellitus and glycaemic factors with primary tumours of the central nervous system.

Li Y, Lin L, Zhang W, Wang Y, Guan Y BMC Neurol. 2024; 24(1):458.

PMID: 39581977 PMC: 11587545. DOI: 10.1186/s12883-024-03969-6.


The causal relationship between immune cell traits and schizophrenia: a Mendelian randomization analysis.

Du J, Baranova A, Zhang G, Zhang F Front Immunol. 2024; 15:1452214.

PMID: 39399496 PMC: 11466782. DOI: 10.3389/fimmu.2024.1452214.


References
1.
Machhi J, Kevadiya B, Muhammad I, Herskovitz J, Olson K, Mosley R . Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Mol Neurodegener. 2020; 15(1):32. PMC: 7275301. DOI: 10.1186/s13024-020-00375-7. View

2.
Wijeyekoon R, Kronenberg-Versteeg D, Scott K, Hayat S, Jones J, Clatworthy M . Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis. Front Neurol. 2018; 9:870. PMC: 6198066. DOI: 10.3389/fneur.2018.00870. View

3.
Hartwig F, Davey Smith G, Bowden J . Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017; 46(6):1985-1998. PMC: 5837715. DOI: 10.1093/ije/dyx102. View

4.
Yang Y, Pan D, Gong Z, Tang J, Li Z, Ding F . Decreased blood CD4+ T lymphocyte helps predict cognitive impairment in patients with amyotrophic lateral sclerosis. BMC Neurol. 2021; 21(1):157. PMC: 8039093. DOI: 10.1186/s12883-021-02185-w. View

5.
Reynolds A, Banerjee R, Liu J, Gendelman H, Mosley R . Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease. J Leukoc Biol. 2007; 82(5):1083-94. DOI: 10.1189/jlb.0507296. View